GHA
MEDP icon

GW Henssler & Associates’s Medpace MEDP Stock Holding History

GW Henssler & Associates’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-552
Closed -$227K – 209
2024
Q2 		$227K Sell
552
-3
-0.5% -$1.19K 0.01% 146
2024
Q1 		$224K Buy
+555
New +$195K 0.01% 148
2023
Q4 		– Sell
-860
Closed -$208K – 189
2023
Q3 		$208K Buy
+860
New +$220K 0.01% 182

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GW Henssler & Associates's MEDP Position: Q3 2024 in Review

GW Henssler & Associates sold out of Medpace (MEDP) in Q3 2024, closing a stake of 552 shares — an estimated $227K sold.

GW Henssler & Associates first reported a position in MEDP in Q3 2023 and held it in 3 quarters. The position peaked at $227K in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • GW Henssler & Associates reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • GW Henssler & Associates sold 552 Medpace shares in Q3 2024, an estimated $227K.
  • GW Henssler & Associates first reported a position in Medpace in Q3 2023 and held it in 3 quarters.
  • GW Henssler & Associates's Medpace position peaked at $227K in Q2 2024.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on GW Henssler & Associates's 13F filing for Q3 2024, filed 25 Oct 2024.